(5Z)-5-[(1,3-benzodioxo-5-yl)methylene]-3-methyl-2-[2-(3,4,5-trimethoxybenzylamino)ethylamino]-3,5-dihydro-4Himidazol-4-one

ID: ALA1081242

Chembl Id: CHEMBL1081242

PubChem CID: 135860200

Max Phase: Preclinical

Molecular Formula: C24H28N4O6

Molecular Weight: 468.51

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(CNCCNC2=N/C(=C\c3ccc4c(c3)OCO4)C(=O)N2C)cc(OC)c1OC

Standard InChI:  InChI=1S/C24H28N4O6/c1-28-23(29)17(9-15-5-6-18-19(10-15)34-14-33-18)27-24(28)26-8-7-25-13-16-11-20(30-2)22(32-4)21(12-16)31-3/h5-6,9-12,25H,7-8,13-14H2,1-4H3,(H,26,27)/b17-9-

Standard InChI Key:  WPMMAGYQFPUGFU-MFOYZWKCSA-N

Alternative Forms

  1. Parent:

    ALA1081242

    ---

Associated Targets(Human)

CSNK2B Tbio Casein kinase I isoform alpha/subunit beta (18 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK5 Tchem Cyclin-dependent kinase 5/CDK5 activator 1 (3697 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3A Tclin Glycogen synthase kinase-3 (736 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 468.51Molecular Weight (Monoisotopic): 468.2009AlogP: 1.99#Rotatable Bonds: 9
Polar Surface Area: 102.88Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.29CX LogP: 1.76CX LogD: 1.51
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.43Np Likeness Score: -0.31

References

1. Debdab M, Renault S, Lozach O, Meijer L, Paquin L, Carreaux F, Bazureau JP..  (2010)  Synthesis and preliminary biological evaluation of new derivatives of the marine alkaloid leucettamine B as kinase inhibitors.,  45  (2): [PMID:19879673] [10.1016/j.ejmech.2009.10.009]

Source